Efficacy and safety of second photodynamic therapy for local failure after salvage photodynamic therapy for esophageal cancer. Issue 3 (21st July 2021)

• Record Type: Journal Article
• Authors: Yamashita, Hiroki; Kadota, Tomohiro; Minamide, Tatsunori; Sunakawa, Hironori; Sato, Daiki; Takashima, Kenji; Nakajo, Keiichiro; Murano, Tatsuro; Shinmura, Kensuke; Yoda, Yusuke; Ikematsu, Hiroaki; Yano, Tomonori
• Is Part Of: Digestive endoscopy. Volume 34:Issue 3(2022)
• Page Start: 488
• Page End: 496
• Publication Date: 2021-07-21
• Subjects: chemoradiotherapy -- esophageal squamous cell carcinoma -- photodynamic therapy -- salvage treatment -- talaporfin sodium; Digestive organs -- Diseases -- Periodicals; Digestive organs -- Diseases -- Diagnosis -- Periodicals; Endoscopy -- Periodicals; Digestive System Diseases -- diagnosis -- Periodicals; Digestive System Diseases -- therapy -- Periodicals; Endoscopy -- Periodicals; 616.3
• DOI: 10.1111/den.14072
• Languages: English
• ISSNs: 0915-5635

Abstract

Abstract : Objectives: Photodynamic therapy (PDT) is an optional salvage treatment for local failure of esophageal squamous cell carcinoma (ESCC) after chemoradiotherapy; however, local failure after PDT sometimes occurs. In such cases, second PDT is sometimes attempted, but its outcomes remain unclear. This study aimed to evaluate the efficacy and safety of second PDT. Methods: We enrolled patients who underwent PDT for local failure of ESCC after chemoradiotherapy. We retrospectively evaluated local‐complete response (L‐CR) rate and clinical outcomes of first and second PDT. The indications for PDT were lesions within the muscle layer, <3 cm in size, and <3/4 of the esophageal circumference; not suitable for salvage surgery; and absence of metastasis. Second PDT was avoided when lesions were apparently refractory to first PDT, e.g. persistence of submucosal tumor‐like protruded component or rapid regrowth of tumor at the ulceration after first PDT. L‐CR was defined as endoscopic disappearance of tumor and post‐PDT ulcer and absence of cancer cells histologically. Results: Among 82 patients who underwent first PDT, 27 underwent second PDT. The L‐CR rates with first and second PDT were 63.0% and 40.7%, respectively. The 2‐year overall survival rates after second PDT in patients with L‐CR and local‐nonCR were 79.5% and 40.5%, respectively. Five of 11 patients with L‐CR survived without any recurrence. No grade ≥3 adverse events occurred. Conclusions: Second PDT demonstrated excellent safety and acceptable efficacy; therefore, it could be a useful treatment for local failure after first PDT.